Korsana Biosciences (KRSA) Cash from Financing (Quarterly): 0.00

Korsana Biosciences, Inc. (KRSA)

30.14 -0.08 (-0.26%) USD | NASDAQ | Oct 30, 16:00

30.13 -0.01 (-0.03%) After-Hours: 20:00

Cash from Financing (Quarterly) Chart

Historical Cash from Financing (Quarterly) Data

View and export this data back to 2017. Start Trial.

Date	Value
June 30, 2026	0.00
March 31, 2026	0.825M
December 31, 2025	0.251M
September 30, 2025	1.826M
June 30, 2025	-0.13M
March 31, 2025	1.375M
December 31, 2024	0.00
September 30, 2024	0.00
June 30, 2024	0.00
March 31, 2024	0.00
December 31, 2023	0.00
September 30, 2023	0.00
June 30, 2023	5.024M
March 31, 2023	0.00
December 31, 2022	0.012M
September 30, 2022	0.00
June 30, 2022	0.017M
March 31, 2022	0.00

Date	Value
December 31, 2021	0.085M
September 30, 2021	0.043M
June 30, 2021	30.63M
March 31, 2021	0.027M
December 31, 2020	0.159M
September 30, 2020	24.27M
June 30, 2020	3.663M
March 31, 2020	0.001M
December 31, 2019	0.145M
September 30, 2019	0.365M
June 30, 2019	174.98M
March 31, 2019	36.08M
December 31, 2018	24.97M
September 30, 2018	26.46M
June 30, 2018	22.92M
March 31, 2018	26.59M
December 31, 2017	26.23M

Cash From Financing Definition

Represents the net cash flow resulting from the company's financing activities. Financing activities represent movement in the company's debt and share capital and other activities.

Read full definition.

Cash from Financing (Quarterly) Range, Past 5 Years

View Cash from Financing (Quarterly) Range, Past 5 Years

Start Trial

Minimum

Maximum

Average

Median

Cash from Financing (Quarterly) Benchmarks

View Cash from Financing (Quarterly) Benchmarks